NEW YORK — Spanish diabetes testing firm Patia said today that it has signed an agreement to market its type 2 diabetes (T2D) risk test in the US through GX Sciences.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.